Company plans to initiate a Phase 1 clinical study by 1H2026 and share data in 2027 NEOK Bio, Inc., an oncology therapeutics company focused on the development of novel antibody drug conjugates (ADCs) ...

** When you buy products through the links on our site, we may earn a commission that supports NRA's mission to protect, preserve and defend the Second Amendment. ** Springfield Armory has announced ...

“We are providing proof that a biotech can develop best-in-class therapies for historically neglected diseases, push the envelope for scientific innovation, prioritize patients and the planet, and ...

Dispatch Bio, a biotech company engineering a universal treatment across solid tumors leveraging its first-in-class Flare platform, today announced that the U.S. Food and Drug Administration (FDA) has ...

New research found that humid heat can be most extreme in the Middle East and North Africa. Such regions are vulnerable to this and other effects of climate change, including 2021 flooding in Sudan, ...

Environmental factors including temperature, humidity, air quality, and seasonal changes can significantly impact idiopathic pulmonary fibrosis (IPF). These triggers can exacerbate symptoms and lead ...

JERUSALEM, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides and proteins replacement therapies, today announced new ...

The FDA has cleared the use of GSK’s Blujepa for the treatment of uncomplicated urogenital gonorrhea, unlocking the first new type of antibiotic for the infection in more than three decades. With the ...

WILMINGTON, Del.--(BUSINESS WIRE)--NiKang Therapeutics Inc. (“NiKang”), a clinical stage biotech company focused on developing innovative small molecule oncology medicines to bring transformative ...

The Big Ten has caught up with the SEC. After winning back-to-back national titles and having No. 1 and No. 2 teams in the polls, the Big Ten is flexing. And that includes in recruiting. Along with ...